In a similar vein, some of you may have noticed that SUN against all predictions, has zoomed up about 400% this year. SUN are in a different part of the medical market, but like MLS, had a bad run with some poor management decisions. The team that took over focussed on FUNDAMENTALS of running a company and the price eventually reflected that, but it took a couple of years of good profit growth for the SP gain to kick in. Results in March will be the first step to MLS heading back to 40+p. HNY to all.